Aldeyra Therapeutics, Inc. (ALDX)

NASDAQ: ALDX · Real-Time Price · USD

1.540

+0.060 (4.05%)

At close: Sep 8, 2026, 4:00 PM EDT

1.530

+0.050 (3.38%)

After-hours: Sep 8, 2026, 7:30 PM EDT

Aldeyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	45.09	70.04	54.53	142.82	144.42	104.79
Short-Term Investments	-	-	46.62	-	29.88	-
Cash & Short-Term Investments	45.09	70.04	101.15	142.82	174.3	104.79
Cash Growth	-44.96%	-30.76%	-29.18%	-18.06%	66.33%	98.25%
Other Receivables	-	-	-	-	3.24	0.03
Receivables	-	-	-	-	3.24	125.03
Prepaid Expenses	1.66	0.7	0.71	0.52	0.87	0.53
Other Current Assets	0.63	1.04	2.21	4.46	2.61	2.4
Total Current Assets	47.38	71.78	104.07	147.81	181.02	232.75
Property, Plant & Equipment	0.16	0.28	0.27	0.52	0.27	0.38
Long-Term Deferred Charges	-	-	0.27	-	-	-
Total Assets	47.54	72.06	104.61	148.33	181.29	233.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.14	0.16	0.18	1.34	0.13	1.02
Accrued Expenses	3.37	6.12	12.12	5.54	14.07	10.52
Current Portion of Long-Term Debt	-	15.25	0.03	15.15	0.91	-
Current Portion of Leases	0.14	0.28	0.27	0.24	0.25	0.23
Current Unearned Revenue	6	6	6	-	-	-
Total Current Liabilities	9.66	27.81	18.6	22.26	15.36	11.77
Long-Term Debt	-	-	15	-	14.92	15.5
Long-Term Leases	-	-	-	0.27	-	0.13
Long-Term Unearned Revenue	-	-	-	6	-	-
Total Liabilities	9.66	27.81	33.6	28.53	30.28	27.4

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	530.69	528.15	521.02	513.99	507.77	500.37
Retained Earnings	-492.86	-483.96	-450.11	-394.26	-356.72	-294.69
Comprehensive Income & Other	-	-	0.04	-	-0.1	-
Shareholders' Equity	37.89	44.25	71	119.8	151.01	205.74
Total Liabilities & Equity	47.54	72.06	104.61	148.33	181.29	233.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.14	15.53	15.3	15.66	16.08	15.86
Net Cash (Debt)	44.95	54.51	85.85	127.17	158.22	88.93
Net Cash Growth	-32.27%	-36.50%	-32.49%	-19.63%	77.91%	136.96%
Net Cash Per Share	0.75	0.91	1.44	2.16	2.71	1.65
Filing Date Shares Outstanding	60.33	60.18	59.71	58.9	58.58	58.1
Total Common Shares Outstanding	60.32	60.16	59.65	59.2	58.56	58.08
Working Capital	37.72	43.97	85.47	125.55	165.66	220.98
Book Value Per Share	0.63	0.74	1.19	2.02	2.58	3.54
Tangible Book Value	37.89	44.25	71	119.8	151.01	205.74
Tangible Book Value Per Share	0.63	0.74	1.19	2.02	2.58	3.54

SEC Filings: 10-K · 10-Q